Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population

References

• Donnan GA, Fisher M, Macleod M, Stroke. Lancet 2008;371:1612–23.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang D, Wong KS, Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011;42:3651–4.
   PubMed Web of Science ®Google Scholar
• Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004;35:212–27.
   PubMed Web of Science ®Google Scholar
• Jeffs B, Clark JS, Anderson NH, Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet 1997;16:364–7.
   PubMed Web of Science ®Google Scholar
• Casas JP, Hingorani AD, Bautista LE, Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol 2004;61:1652–61.
   PubMed Web of Science ®Google Scholar
• Ariyaratnam R, Casas JP, Whittaker J, Genetics of Ischaemic Stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals. PLoS Med 2007;4:e131.
   PubMed Web of Science ®Google Scholar
• Albers GW, Amarenco P, Easton JD, Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:630S–69S.
   PubMedGoogle Scholar
• Tuttolomondo A, Pinto A, Corrao S, Immunoinflammatory and thrombotic/fibrinolytic variables associated with acute ischemic stroke diagnosis. Atherosclerosis 2009;203: 503–8.
   PubMed Web of Science ®Google Scholar
• de Paula Sabino A, Ribeiro DD, Domingueti CP, Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke. Mol Biol Rep 2011;38:5355–60.
   PubMed Web of Science ®Google Scholar
• Erikson P, Kallin B, Van'T Hooft FM, Allele-specific increase in basal transcription of plasminogen activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851–5.
   PubMed Web of Science ®Google Scholar
• Grubic N, Stegnar M, Peternel P, A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis. Thromb Res 1996;84:431–43.
   PubMed Web of Science ®Google Scholar
• Henry M, Chomiki N, Scarabin PY, Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol 1997;17: 851–8.
   PubMed Web of Science ®Google Scholar
• Tsantes AE, Nikolopoulos GK, Bagos PG, Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis. Blood Coagul Fibrinolysis 2007;18:497–504.
   PubMed Web of Science ®Google Scholar
• Bentley P, Peck G, Smeeth L, Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS One 2010;5:e9136.
   PubMed Web of Science ®Google Scholar
• Babu MS, Prabha TS, Kaul S, Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene 2012;495:76–80.
   PubMed Web of Science ®Google Scholar
• Xu X, Li J, Sheng W, Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese Population. Cerebrovasc Dis 2008;26:48–62.
   Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 1959;22:719–48.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li J, Li L, The study of PAI-1 promotor region gene polymorphism in cerebrovascular disease. Chin J Med Genet 2001;18:384–7.
   Google Scholar
• Guan LX, Wang JX, Wang RL, Effect of gene polymorphism of PAI - 1 gene promotor region on patients with essential hypertension complicated by cerebral infarction. Chin J Geriatr 2004;23:756–8.
   Google Scholar
• Yi GH. A study of the plasma plasminogen-activator inhibitor 1 activity and its promoter region gene polymorphism in acute cerebral infarction. Acta Academiae Medicine Qingdao Universitatis 2004;40:229–31.
   Google Scholar
• Liu SJ, Yang LH, Wang XD, The study of the plasma P AI - 1 activity and its promotor region gene polymorphism in acute cerebral infarction. Chin J Neurol 1998;31:264–6.
   Google Scholar
• Xu B, Zhang CY, Xian BX. A study of the plasma plasminogen activator inhibitor-1 activity and its promoter region 4G/5G gene polymorphism in acute cerebral infarction. Zhong Guo Yi Shi Jin Xiu Za Zhi 2006;29:26–8.
   Google Scholar
• Zhang YD, Sun Q, Liu Y, The association of PAI-1 gene polymorphism with cerebral infarction and recurrent cerebral infarction. J Clin Neurol 2001;14:262–5.
   Google Scholar
• Liu Z, Zhao B. The association of beta fibrinogen 148 C/T gene and plasminogen activator inhibitor 1-675 4G/5G gene polymorphisms with cerebral infarction. Nervous Diseases and Mental Health 2008;8:94–7.
   Google Scholar
• Tang XB, Chen DM, Geng DQ, Association between 4G/ 5G genetic polymorphisms in the promotor region of the plasminogen activator inhibitor-1 and recurrent cerebral infarction. Nervous Diseases and Mental Health 2005;5:118–20.
   Google Scholar
• Tang XB, Liu SX, Geng DQ, Association between 4G/5G genetic polymorphisms in the promotor region of the plasminogen activator inhibitor-1 and stroke. Nervous Diseases and Mental Health 2008;8:33–7.
   Google Scholar
• Chen CH, Eng HL, Chang CJ, 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 2003;142:100–5.
   PubMed Web of Science ®Google Scholar
• Yeh PS, Lin HJ, Li YH, Prognosis of young ischemic stroke in Taiwan: impact of prothrombotic genetic polymorphisms. Thromb Haemost 2004;92:583–9.
   PubMed Web of Science ®Google Scholar
• Bang CO, Park HK, Ahn MY, 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/ deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc Dis 2001;11:294–9.
   PubMed Web of Science ®Google Scholar
• Wiklund PG, Nilsson L, Ardnor SN, Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts. Stroke 2005;36:1661–5.
   PubMed Web of Science ®Google Scholar
• Saidi S, Slamia LB, Mahjoub T, Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007;16:153–9.
   PubMedGoogle Scholar
• Attia J, Thakkinstian A, Wang Y, The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J Stroke Cerebrovasc Dis 2007;16: 173–9.
   PubMedGoogle Scholar
• Ding J, Nicklas BJ, Fallin MD, Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J 2006;152:1109–15.
   PubMed Web of Science ®Google Scholar
• Hassan A, Gormley K, O'Sullivan M, Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004;35:654–9.
   PubMed Web of Science ®Google Scholar
• Dichgans M, Markus HS. Genetic association studies in stroke: methodological issues and proposed standard criteria. Stroke 2005;36:2027–31.
   PubMed Web of Science ®Google Scholar
• Stegnar M, Uhrin P, Peternel P, The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 1998;79:975–9.
   PubMed Web of Science ®Google Scholar
• Grancha S, Estelles A, Tormo G, Plasminogen activator inhibitor-1 promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease. Thromb Haemost 1999;81:516–21.
   PubMed Web of Science ®Google Scholar